Company Overview
VIRIDIAN THERAPEUTICS, INC.DE
VRDNRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-343M
2025 FY
Shares Outstanding
85M
2025 FY
EPS
-3.32USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1590750
Exchange
Nasdaq
Location
US